RE:2016Someone named Scot really likes this stock... ;-)
Quattro74 wrote:
Should be a great year for investors of TLT.
First we should get the green light to move forward with our phase 1 nmibc study.
Also, each quarter our sales and projections should improve for the pain and healing sector. The idea of light as medicine is catching on in North America and we should get approval in Europe, who are already open to the idea.
Roger White has said for years that he is angling for both fast-track status and a buyout. I think we could see progress on both in 2016.
Research will continue for other indications that can be applied topically and that can also be rolled out once our nmibc treatment is approved, I don't have to tell anyone what our sp will be once we have approval and multiple indications in the pipeline :-)
As bencro has sluthed, we now have a new tech in development that will allow PDTs to be directly injected into tumors, this once approved means no lengthy and expensive large animal trials for our PDCs to be used for virtually all indications. Dr. Lilge alluded to this possibility in the 2014 AGM video now that mystery is solved.
Most of the risk of owning this stock is behind us, only HC ITA approval remains. The largest risk is not owning any shares once word gets out about this very exciting tech.
Also, remaining on the venture exchange could mean no one pays attention, Hopefully the market will allow us to begin that move this year. The share price should begin a stair-step pattern with an upward trajectory. IF we get high enough we could possibly end up on a real exchange. Markets anticipate so I don't think we will have to worry about these low prices much longer, we will have spikes and pullbacks, people will trade these and that's great, I have my position at a good price and I am holding until the eventual buyout.
GLTA and happy new year!